Nephros Inc. (NEP) Enters Into Hemodiafilter Manufacturing And Distribution Rights Agreement With Asahi Kasei Medical
10/19/2005 5:12:54 PM
NEW YORK--(BUSINESS WIRE)--March 2, 2005--Nephros, Inc. (AMEX: NEP) today announced it has entered into an agreement with Asahi Kasei Medical Co., Ltd., a business unit of Asahi Kasei Corporation, granting Asahi Kasei Medical exclusive rights to manufacture and distribute filter products based on the Nephros OLpur (TM) MD190 hemodiafilter in Japan for 10 years. In addition to an initial license fee, royalties and milestone payments, Asahi Kasei Medical will make an investment in Nephros common stock. Asahi Kasei Medical is the leading provider of dialysis filters in Japan and one of the three largest dialyzer providers in the world. The announcement was made by Nephros CEO Norman Barta.
comments powered by